Insights Center
Thought leadership, news, events — you will find them all here, right at your fingertips. We’ve consolidated the firm’s most popular content in one, easy to search location. Enter a key word or phrase to find pertinent blog posts, articles, press releases, and upcoming events.
Mintz Direct
Mintz Viewpoints
Showing 9529 - 9536 of 12089 results
FTC and DOJ: The PTO’s Efforts to Enhance Patent Quality Will Promote Competition, Innovation, and Consumer Welfare
May 7, 2015| Blog| Viewpoint
ML Strategies: 21st Century Cures Initiative and Pioneer ACO Expansion
May 7, 2015| Blog| Viewpoint
ONC Releases Privacy and Security Guidance Geared Toward Small Providers
May 7, 2015| Blog| Viewpoint
Breaking Down the DOJ Cybersecurity Unit’s Guidance on Responding to Cyberattacks
May 7, 2015| Blog| Viewpoint
Quick Update on the Obama Administration's Efforts to Update the FLSA White Collar Exemptions
May 6, 2015| Blog| Viewpoint
EPA’s Proposed Nano Rule: What Should You Be Doing Now?
May 6, 2015| Blog| Viewpoint
Maximizing Use of the USPTO's Patent Application Alert Service
May 6, 2015| Blog| Viewpoint
Medicare Part D Data Release Continues Transparency Trend
May 6, 2015| Blog| Viewpoint
News & Press Releases
Mintz advised the creators of Morbid, one of the top-charting true crime podcasts, in a multi-year agreement to move to SiriusXM from Wondery. The deal gives SiriusXM exclusive advertising rights for the audio and video formats of the podcast.
Mintz Advises CVC DIF in Acquisition of SBA Communications’ Canadian Tower Infrastructure Platform
August 06, 2025
Mintz advised CVC DIF, the dedicated infrastructure investment strategy of global private markets manager CVC, in its agreement to acquire SBA Communications’ Canadian wireless tower business, one of Canada’s leading independent owners and operators of wireless communications towers. The transaction is expected to close in the fourth quarter of 2025, subject to customary closing conditions.
Mintz advised the underwriters in connection with a $69 million public offering by Larimar Therapeutics, Inc. of 21,562,500 shares of its common stock at a price to the public of $3.20 per share. The gross proceeds to Larimar from the offering were $69 million before deducting underwriting discounts and commissions and other offering expenses.
Events
Podcasts
Mintz On Air: Practical Policies — A Private Equity Non-Compete Primer
July 15, 2025| Podcast|
Health Law Diagnosed – Best Practices for Communicating with the FDA
July 9, 2025| Podcast|